Get it on Google Play

ChemGenex (CXSP) Granted Orphan Drug Status for Ceflatonin

March 20, 2006 12:27 AM EST Send to a Friend
Late Sunday, ChemGenex Pharmaceuticals Limited (Nasdaq: CXSP) announced the FDA has granted Orphan Drug status for its ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login